Coreg and Entecavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Entecavir (entecavir). Common drug interactions include chronic kidney disease among females and musculoskeletal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Entecavir. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

15 people who take Coreg and Entecavir together, and have interactions are studied.

What are the common drug interactions of Coreg and Entecavir, by gender? *:

female:

Chronic kidney disease
Renal injury (kidney injury)
Hypotension (abnormally low blood pressure)
Respiratory distress (difficulty in breathing)
Anaemia (lack of blood)
Anxiety
Blood creatinine increased
Depression
Dyspnoea (difficult or laboured respiration)
Empyema (collection of pus in a cavity in the body)

male:

Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Neuralgia (pain in one or more nerves)
Rectal haemorrhage (bleeding from anus)
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Death
Emotional distress
Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Coreg and Entecavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal injury (kidney injury)
Anxiety
Blood creatinine increased
Depression
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal hypertension (high blood pressure caused by the kidneys hormonal response)

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Death
Emotional distress
Nephrolithiasis (calculi in the kidneys)
Pain
Proteinuria (presence of protein in the urine)
Renal failure (kidney dysfunction)

50-59:

n/a

60+:

Hypotension (abnormally low blood pressure)
Respiratory distress (difficulty in breathing)
Acute respiratory failure
Hypoxia (low oxygen in tissues)
Leukocytosis (increased white blood cells)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pleural effusion (water on the lungs)
Rectal haemorrhage (bleeding from anus)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urine output decreased

What are the existing conditions these people have? *

Pain: 5 people, 33.33%
Nausea And Vomiting: 3 people, 20.00%
Nausea (feeling of having an urge to vomit): 3 people, 20.00%
Hiv Infection: 3 people, 20.00%
Fever: 3 people, 20.00%
Renal Disorder (kidney disease): 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Bipolar Disorder (mood disorder): 2 people, 13.33%
Cough: 2 people, 13.33%
Diabetes: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Entecavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously